Geulah Livshits
Stock Analyst at Chardan Capital
(4.20)
# 1,489
Out of 4,531 analysts
654
Total ratings
36.5%
Success rate
7.9%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Geulah Livshits
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MGX Metagenomi Therapeutics | Maintained: Buy | $7 → $5 | $1.24 | +303.23% | 8 | Jul 7, 2026 | |
| PVLA Palvella Therapeutics | Reiterated: Buy | $240 | $157.24 | +52.63% | 12 | May 20, 2026 | |
| IMTX Immatics | Reiterated: Buy | $25 | $9.59 | +160.69% | 22 | May 19, 2026 | |
| IMRX Immuneering | Reiterated: Buy | $20 | $4.64 | +331.03% | 15 | May 19, 2026 | |
| SNTI Senti Biosciences Holdings | Reiterated: Buy | $13 → $12 | $0.437 | +2,646.00% | 12 | May 15, 2026 | |
| TNYA Tenaya Therapeutics | Reiterated: Buy | $8 | $0.817 | +879.19% | 21 | May 15, 2026 | |
| SLDB Solid Biosciences | Reiterated: Buy | $15 | $8.72 | +72.02% | 12 | May 13, 2026 | |
| LXEO Lexeo Therapeutics | Reiterated: Buy | $17 | $4.69 | +262.47% | 13 | May 11, 2026 | |
| RCKT Rocket Pharmaceuticals | Reiterated: Buy | $11 | $3.44 | +219.77% | 39 | May 10, 2026 | |
| FDMT 4D Molecular Therapeutics | Reiterated: Buy | $26 | $10.99 | +136.58% | 17 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $3.13 | +187.54% | 6 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $14 | $5.00 | +180.00% | 53 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $5.96 | +101.34% | 28 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3.5 → $4 | $2.98 | +34.23% | 43 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 | $12.70 | +73.23% | 1 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $76 | $47.78 | +59.06% | 57 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $323 | $354.86 | -8.98% | 24 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $27 → $30 | $11.38 | +163.74% | 51 | Apr 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $120 → $21 | $4.83 | +334.78% | 17 | Nov 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $61.82 | - | 41 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €1.00 | €0.26 | +284.62% | 8 | Sep 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 → $7 | $2.25 | n/a | 7 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $4.56 | n/a | 23 | Jan 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $41 → $36 | $12.44 | n/a | 18 | Dec 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $40.25 | n/a | 6 | Aug 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $2.83 | n/a | 11 | Mar 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.7349 | n/a | 12 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $6.05 | n/a | 3 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 | $9.04 | n/a | 1 | Dec 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €15.00 | €0.08 | n/a | 7 | Jul 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $90 → $76 | $9.89 | n/a | 6 | Mar 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4 → $6 | $3.17 | n/a | 3 | Mar 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 → $15 | $15.05 | n/a | 10 | Feb 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 → $20 | $40.26 | n/a | 3 | Jan 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $0.0151 | n/a | 5 | Dec 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 → $21 | $22.32 | n/a | 2 | Aug 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.00001 | n/a | 17 | Jul 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 → $48 | $10.23 | n/a | 9 | Oct 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $28 | $1.74 | n/a | 1 | Jun 4, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1 | $48.86 | n/a | 10 | Feb 20, 2020 |
Metagenomi Therapeutics
Jul 7, 2026
Maintained: Buy
Price Target: $7 → $5
Current: $1.24
Upside: +303.23%
Palvella Therapeutics
May 20, 2026
Reiterated: Buy
Price Target: $240
Current: $157.24
Upside: +52.63%
Immatics
May 19, 2026
Reiterated: Buy
Price Target: $25
Current: $9.59
Upside: +160.69%
Immuneering
May 19, 2026
Reiterated: Buy
Price Target: $20
Current: $4.64
Upside: +331.03%
Senti Biosciences Holdings
May 15, 2026
Reiterated: Buy
Price Target: $13 → $12
Current: $0.437
Upside: +2,646.00%
Tenaya Therapeutics
May 15, 2026
Reiterated: Buy
Price Target: $8
Current: $0.817
Upside: +879.19%
Solid Biosciences
May 13, 2026
Reiterated: Buy
Price Target: $15
Current: $8.72
Upside: +72.02%
Lexeo Therapeutics
May 11, 2026
Reiterated: Buy
Price Target: $17
Current: $4.69
Upside: +262.47%
Rocket Pharmaceuticals
May 10, 2026
Reiterated: Buy
Price Target: $11
Current: $3.44
Upside: +219.77%
4D Molecular Therapeutics
May 8, 2026
Reiterated: Buy
Price Target: $26
Current: $10.99
Upside: +136.58%
May 8, 2026
Reiterated: Buy
Price Target: $9
Current: $3.13
Upside: +187.54%
May 7, 2026
Reiterated: Buy
Price Target: $16 → $14
Current: $5.00
Upside: +180.00%
May 6, 2026
Reiterated: Buy
Price Target: $12
Current: $5.96
Upside: +101.34%
May 5, 2026
Reiterated: Buy
Price Target: $3.5 → $4
Current: $2.98
Upside: +34.23%
May 5, 2026
Maintained: Buy
Price Target: $22
Current: $12.70
Upside: +73.23%
May 4, 2026
Reiterated: Buy
Price Target: $76
Current: $47.78
Upside: +59.06%
May 4, 2026
Reiterated: Buy
Price Target: $323
Current: $354.86
Upside: -8.98%
Apr 27, 2026
Maintained: Buy
Price Target: $27 → $30
Current: $11.38
Upside: +163.74%
Nov 12, 2025
Maintained: Buy
Price Target: $120 → $21
Current: $4.83
Upside: +334.78%
Oct 7, 2025
Rated: Hold
Price Target: n/a
Current: $61.82
Upside: -
Sep 17, 2025
Maintained: Buy
Price Target: €1.00
Current: €0.26
Upside: +284.62%
Mar 24, 2025
Maintained: Buy
Price Target: $11 → $7
Current: $2.25
Upside: n/a
Jan 29, 2024
Reiterated: Buy
Price Target: n/a
Current: $4.56
Upside: n/a
Dec 21, 2023
Reiterated: Buy
Price Target: $41 → $36
Current: $12.44
Upside: n/a
Aug 25, 2023
Initiated Coverage: Buy
Price Target: n/a
Current: $40.25
Upside: n/a
Mar 21, 2023
Reiterated: Buy
Price Target: $12
Current: $2.83
Upside: n/a
Feb 17, 2023
Rated: Hold
Price Target: n/a
Current: $0.7349
Upside: n/a
Jan 6, 2023
Rated: Hold
Price Target: n/a
Current: $6.05
Upside: n/a
Dec 14, 2022
Maintained: Buy
Price Target: $11
Current: $9.04
Upside: n/a
Jul 28, 2022
Reiterated: Buy
Price Target: €15.00
Current: €0.08
Upside: n/a
Mar 29, 2022
Maintained: Buy
Price Target: $90 → $76
Current: $9.89
Upside: n/a
Mar 9, 2022
Reiterated: Hold
Price Target: $4 → $6
Current: $3.17
Upside: n/a
Feb 22, 2022
Reiterated: Buy
Price Target: $25 → $15
Current: $15.05
Upside: n/a
Jan 5, 2022
Reiterated: Buy
Price Target: $22 → $20
Current: $40.26
Upside: n/a
Dec 17, 2021
Reiterated: Buy
Price Target: $30
Current: $0.0151
Upside: n/a
Aug 20, 2021
Reiterated: Buy
Price Target: $18 → $21
Current: $22.32
Upside: n/a
Jul 30, 2021
Rated: Hold
Price Target: n/a
Current: $0.00001
Upside: n/a
Oct 14, 2020
Maintained: Buy
Price Target: $30 → $48
Current: $10.23
Upside: n/a
Jun 4, 2020
Initiated Coverage: Buy
Price Target: $28
Current: $1.74
Upside: n/a
Feb 20, 2020
Reiterated: Hold
Price Target: $1
Current: $48.86
Upside: n/a